1. The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw
- Author
-
Takanori Eguchi, Yukinaga Miyata, Minako Inoue, Ikuyo Kanai, Akihiko Basugi, and Yoshiki Hamada
- Subjects
Male ,medicine.medical_specialty ,Treatment outcome ,MEDLINE ,Dentistry ,Stage ii ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Medicine ,Humans ,General Dentistry ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Research ,Significant difference ,Osteonecrosis ,Non surgical treatment ,Retrospective cohort study ,030206 dentistry ,Drug holiday ,medicine.disease ,CIENCIAS MÉDICAS [UNESCO] ,Treatment Outcome ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,UNESCO::CIENCIAS MÉDICAS ,Surgery ,Female ,Oral Surgery ,business ,Osteonecrosis of the jaw ,Jaw Diseases - Abstract
Background Non-surgical treatment has generally been recommended for stage II medication-related osteonecrosis of the jaw (MRONJ) in preference to surgery. However, non-surgical treatment is not empirically effective. The aim of this study was to evaluate whether surgical or non-surgical treatment leads to better outcomes for stage II MRONJ. Material and Methods In this retrospective study, surgery was performed in a total of 28 patients while 24 patients underwent non-surgical treatment. The outcomes of both treatment approaches after 6 months were evaluated and statistically compared. In addition, risk factors for surgical and non-surgical treatments were assessed for each. Results Surgical treatment in 25 patients (89.3%) resulted in success, with failure in 3 patients (10.7%). Non-surgical treatment was successful for 8 patients (33.3%) and failed in 16 patients (66.7%). There was therefore a significant difference between surgical and non-surgical treatment outcomes (P
- Published
- 2017